AABB's donor hemovigilance efforts focus primarily on education, collaboration with other international organizations, and projects undertaken by the AABB Donor Hemovigilance Working Group.
Please check the resource section to access publications.
The Severity Grading Tool for Donor Adverse Events was developed and validated by a sub-group of the AABB Donor Hemovigilance Working Group. Results of the formal validation study have been published (Transfusion, 2020).
The Severity Grading Tool for Donor Adverse Events was developed to enhance objective assignment of DAE severity. The tool is designed to be used with the Standard for Surveillance of Complications Related to Blood Donation by ISBT/AABB/IHN. The tool aims to avoid terms such as “mild,” “moderate” and “severe.” It is patterned after an established clinical severity scale, Common Terminology Criteria for Adverse Events (CTCAE1) v 5.0, which rates severity by Grades 1-5 with 1 through 5 being roughly associated with mild, moderate, severe, life-threatening and death; reactions of Grade 3 or higher are classed as "serious" in donor adverse event reporting systems.
Questions? Contact
Hemovigilance@aabb.org or +1.301.215.6588.
Next Virtual Journal Club Begins Tuesday
May 08, 2024
UK Issues National Patient Safety Alert on Reducing TACO Risk
April 05, 2024
Registration Open for IHN Symposium 2024
March 27, 2024